Your Progress | Vanguard Vault

Progress

Your baseline and follow-up results

Every priority marker and physical measure is shown beside its baseline, with the change and direction of travel.

12 March 20269 September 2026

Lab markers improved

51/53

Physical measures improved

23/23

Biological age

−5.6 yrs

Endocrine - full axis

Testosterone axis

Marker	Baseline	Follow-up	Change	Status
Total testosteroneng/dL	412	698	+69%	In range
Free testosteronepg/mL	61	128	+110%	In range
Bioavailable testosteroneng/dL	148	276	+86%	In range
SHBGnmol/L	52	41	−21%	In range
Albuming/dL	4.1	4.4	+7%	Optimal
Free androgen indexratio	27	59	+119%	Optimal
LHIU/L	2.1	3.6	+71%	Optimal
FSHIU/L	2.4	3.1	+29%	Optimal
Estradiol (sensitive)pg/mL	14	23	+64%	Optimal
Testosterone : estradiol ratioratio	29.4	30.3	+3%	Optimal
DHEA-Sµg/dL	188	246	+31%	In range
Prolactinng/mL	13.8	10.6	−23%	In range
Progesteroneng/mL	0.14	0.22	+57%	Optimal
PSA, totalng/mL	0.8	0.9	+12%	Optimal

Longevity - atherogenic burden

Cardiovascular risk

Marker	Baseline	Follow-up	Change	Status
ApoBmg/dL	118	89	−25%	In range
Lp(a)nmol/L	46	45	−2%	Optimal
LDL particle numbernmol/L	1486	1168	−21%	In range
LDL cholesterolmg/dL	142	109	−23%	Out of range
HDL cholesterolmg/dL	42	49	+17%	In range
Triglyceridesmg/dL	186	118	−37%	In range
Triglyceride : HDL ratioratio	4.4	2.4	−45%	In range
Remnant cholesterolmg/dL	34	22	−35%	In range
Omega-3 index%	4.2	7.1	+69%	In range

Longevity - glycaemic control

Metabolic & inflammatory

Marker	Baseline	Follow-up	Change	Status
Fasting insulinµIU/mL	14.2	7.8	−45%	In range
HOMA-IRindex	3.4	1.7	−50%	In range
Fasting glucosemg/dL	98	89	−9%	In range
HbA1c%	5.6	5.3	−5%	In range
hs-CRPmg/L	2.8	1.1	−61%	In range
Homocysteineµmol/L	12.4	9.2	−26%	In range
Uric acidmg/dL	6.9	5.9	−14%	In range
IGF-1ng/mL	96	128	+33%	Optimal
Leptinng/mL	11.8	7.4	−37%	In range

Systems - capacity and clearance

Organ function & thyroid

Marker	Baseline	Follow-up	Change	Status
ALTU/L	44	29	−34%	In range
ASTU/L	34	27	−21%	In range
GGTU/L	41	27	−34%	In range
eGFRmL/min/1.73	88	92	+5%	Optimal
Cystatin Cmg/L	0.94	0.86	−9%	In range
Albumin : creatinine ratiomg/g	14	9	−36%	Optimal
TSHmIU/L	3.2	2.3	−28%	In range
Free T3pg/mL	2.6	3.1	+19%	In range
Free T4ng/dL	1	1.2	+20%	Optimal
Reverse T3ng/dL	22	17	−23%	In range

Foundations - substrate availability

Micronutrients & blood

Marker	Baseline	Follow-up	Change	Status
Vitamin D, 25-OHng/mL	22	48	+118%	In range
Vitamin B12pg/mL	318	542	+70%	Optimal
Folate, serumng/mL	6.1	11.4	+87%	Optimal
Magnesium, RBCmg/dL	4.4	5.3	+20%	In range
Zinc, plasmaµg/dL	71	92	+30%	Optimal
Ferritinng/mL	214	156	−27%	In range
Transferrin saturation%	47	38	−19%	Optimal
Haemoglobing/dL	14.6	15.1	+3%	Optimal
Haematocrit%	43.1	45.2	+5%	Optimal
White cell countK/µL	7.9	6.4	−19%	Optimal
PlateletsK/µL	289	271	−6%	Optimal

Physical & performance

Assessment deltas

VO2max

35.240.8+16%

mL/kg/min

Resting heart rate

7162−13%

bpm

HRV (rMSSD)

3244+38%

Heart rate recovery, 1 min

1421+50%

bpm drop

Systolic blood pressure

138124−10%

mmHg

Diastolic blood pressure

8879−10%

mmHg

Body weight

96.490.2−6%

Body fat

27.422.1−19%

Lean mass

66.167.4+2%

Visceral adipose tissue

142104−27%

cm²

Waist : height ratio

0.560.51−9%

ratio

Bone mineral density (T-score)

-0.4-0.3+25%

Grip strength (dominant)

4147+15%

Trap-bar deadlift 3RM

105140+33%

Weighted carry

2045+125%

m at 2 × 32 kg

Dead hang

2248+118%

seconds

Overhead mobility screen

47+75%

score /10

Single-leg balance, eyes closed

918+100%

seconds

Gait speed

1.221.36+11%

m/s

Total sleep time

5.97+19%

hours

Deep sleep

3861+61%

minutes

Sleep efficiency

7686+13%

Nocturnal respiratory events

11.45.8−49%

per hour

Your next phase

Your follow-up shows which parts of the protocol produced a measurable response and where the next 90 days should focus. Your next full panel and assessment are already scheduled.